Have Researchers Just Found Another Cause of Parkinson’s Disease?

Health & LifestyleNews
530

Listen to article (english)

Translate to Spanish or other 102 languages!

New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes
New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers from the University of Copenhagen, in Denmark, have made an important breakthrough in our understanding of Parkinson’s disease.
  • Their discovery centres around the damage of mitochondrial DNA in brain cells and its potential as an early biomarker for the disease.
  • As this condition affects over 10 million individuals worldwide, these findings hold significant promise for the future of diagnostics and treatments.
  • With the implications of these damaged DNA pieces likened to an unchecked forest blaze, the research provides hope and a fresh direction in understanding and treating this condition.

Parkinson’s disease is a neurological condition that impacts movement. Initial symptoms involve shaking, diminished sense of smell and difficulties with coordination.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/have-researchers-just-found-another-cause-of-parkinsons-disease

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Inflammatory Breast Cancer
Next article
From Motherhood to EMT

More Articles

Why Strength Training Is Your Best Defense Against Osteoporosis

Reports show women are at higher risk for developing the bone weakening condition as they get older.

Social Security Administration Corrects Millions of Records in Major Database Cleanup

The Social Security Administration (SSA) announced on October 20, 2026, that it has corrected millions of Social Security number records in what the agency describes as its most comprehensive record-integrity initiative in 91 years.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

A UTHealth Houston Physician Turned a Texas Teen’s Frightening Diagnosis into a Champion Title

Two years ago, Geordon Boulware, now 15, was at a routine dental visit in his hometown of Lufkin, Texas, when his dentist discovered he had an abnormal growth on his jaw. After meeting with a local oral surgeon, Geordon and his mom decided to seek treatment in Houston. 
- Advertisement -